Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients-Reference-Cited by-同舟云学术

Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients

Published:2016-10 Issue: Volume:220 Page:56-60
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Gu Jun,Fan Yu-qi,Han Zhi-hua,Fan Li,Bian Ling,Zhang Hui-li,Xu Zuo-jun,Yin Zhao-fang,Xie Yu-shui,Zhang Jun-feng,Wang Chang-qian

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J. Am. Coll. Cardiol.,2013

2. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction;Tannenbaum;Curr. Opin. Cardiol.,2015

3. Myocardial remodeling in hypertension;Nadruz;J. Hum. Hypertens.,2015

4. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction;Melenovsky;J. Am. Coll. Cardiol.,2007

5. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: a retrospective observational cohort study;Gu;Eur J Prev Cardiol,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study;Advances in Therapy;2024-02-04

2. Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function;Current Medical Research and Opinion;2023-06-21

3. Effects of Mineralocorticoid Receptor Antagonists in Early-Stage Heart Failure With Preserved Ejection Fraction;CJC Open;2023-05

4. Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction;Frontiers in Cardiovascular Medicine;2022-09-09

5. Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options;Cardiology and Therapy;2022-03-30